Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Goodwill (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Goodwill for 13 consecutive years, with $197.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Goodwill changed 0.0% year-over-year to $197.8 million, compared with a TTM value of $197.8 million through Sep 2025, changed 0.0%, and an annual FY2024 reading of $197.8 million, changed 0.0% over the prior year.
  • Goodwill was $197.8 million for Q3 2025 at Amicus Therapeutics, roughly flat from $197.8 million in the prior quarter.
  • Across five years, Goodwill topped out at $197.8 million in Q1 2021 and bottomed at $197.8 million in Q1 2021.
  • Average Goodwill over 5 years is $197.8 million, with a median of $197.8 million recorded in 2021.
  • Peak annual rise in Goodwill hit 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
  • Year by year, Goodwill stood at $197.8 million in 2021, then changed by 0.0% to $197.8 million in 2022, then changed by 0.0% to $197.8 million in 2023, then changed by 0.0% to $197.8 million in 2024, then changed by 0.0% to $197.8 million in 2025.
  • Business Quant data shows Goodwill for FOLD at $197.8 million in Q3 2025, $197.8 million in Q2 2025, and $197.8 million in Q1 2025.